Short answer
Inogen Inc (INGN) filed an 8-K current report with the SEC on April 6, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Item 1.01 disclosure involves a related-person transaction under Regulation S-K Item 404(a).
Inogen Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Item 1.01 disclosure involves a related-person transaction under Regulation S-K Item 404(a)
- Mr. Jamali has no family relationships with Inogen directors or executive officers
Item 5.02 · Departure/Election of Directors or Officers
- Vafa Jamali appointed Class I independent director through 2027 annual meeting
- Audit and Compliance Committee appointments add medical-device turnaround experience
- Former ZimVie CEO and Medtronic executive brings Nasdaq listing and profitability-improvement experience
- Annual cash compensation totals $60,000 across board, Audit, and Compliance Committee service
- Initial RSU award valued at $180,000, vesting after one year or before the 2027 annual meeting
Item 7.01 · Regulation FD Disclosure
- Cooperation Agreement announced, indicating negotiated alignment with an external party
- Mr. Jamali appointed to the Inogen board, changing board composition and governance oversight
- Exhibit 99.1 contains the press release and likely provides agreement terms and appointment context
Item EX-99.1 · Exhibit EX-99.1
- Vafa Jamali appointed independent director effective June 15, 2026, or earlier at Inogen’s 2026 Annual Meeting
- Board gains respiratory-device expertise from former Medtronic executive overseeing a $3 billion division and 10,000 employees
- Appointment supports Inogen’s shift from portable oxygen toward a diversified respiratory-care platform
- Cooperation agreement with activist investor Kent Lake includes standstill and voting provisions, reducing near-term governance uncertainty
- Kent Lake’s stated priorities: organic revenue growth, profitability, cash generation, product innovation, and disciplined capital allocation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inogen Inc 8-K filings
Get the next INGN 8-K as it lands
Follow INGN for push alerts, or ask the research agent what this filing means.